Stable siRNA-mediated silencing of antizyme inhibitor

Regulation of ornithine decarboxylase activity

Kyoung Suk Choi, Young Ho Suh, Won Ho Kim, Tae Ho Lee, Myeong Ho Jung

Research output: Contribution to journalArticleResearchpeer-review

39 Citations (Scopus)

Abstract

Ornithine decarboxylase (ODC) is the rate-limiting enzyme involved in the biosynthesis of polyamines essential for cell growth and differentiation. Aberrant upregulation of ODC, however, is widely believed to be a contributing factor in tumorigenesis. Antizyme is a major regulator of ODC, inhibiting ODC activity through the formation of complexes and facilitating degradation of ODC by the 26S proteasome. Moreover, the antizyme inhibitor (AZI) serves as another factor in regulating ODC, by binding to antizyme and releasing ODC from ODC-antizyme complexes. In our previous report, we observed elevated AZI expression in tumor specimens. Therefore, to evaluate the role of AZI in regulating ODC activity in tumors, we successfully down-regulated AZI expression using RNA interference technology in A549 lung cancer cells expressing high levels of AZI. Two AZI siRNAs, which were capable to generate a hairpin dsRNA loop targeting AZI, could successively decrease the expression of AZI. Using biological assays, antizyme activity increased in AZI-siRNA-transfected cells, and ODC levels and activity were reduced as well. Moreover, silencing AZI expression decreased intracellular polyamine levels, reduced cell proliferation, and prolonged population doubling time. Our results directly demonstrate that downregulation of AZI regulates ODC activity, intracellular polyamine levels, and cell growth through regulating antizyme activity. This study also suggests that highly expressed AZI may be partly responsible for increased ODC activity and cellular transformation.

Original languageEnglish
Pages (from-to)206-212
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume328
Issue number1
DOIs
StatePublished - 4 Mar 2005

Fingerprint

Ornithine Decarboxylase
Small Interfering RNA
Polyamines
Cell growth
Tumors
ornithine decarboxylase antizyme inhibitor
Growth
RNA Interference
Biological Assay
Biosynthesis
Cell proliferation
Cell Differentiation
Lung Neoplasms
Neoplasms
Carcinogenesis
Up-Regulation
Down-Regulation
Cell Proliferation
Assays
Technology

Keywords

  • Antizyme
  • Antizyme inhibitor
  • Ornithine decarboxylase
  • siRNA

Cite this

@article{1f06f1ff6dad4333bf19737b540111d3,
title = "Stable siRNA-mediated silencing of antizyme inhibitor: Regulation of ornithine decarboxylase activity",
abstract = "Ornithine decarboxylase (ODC) is the rate-limiting enzyme involved in the biosynthesis of polyamines essential for cell growth and differentiation. Aberrant upregulation of ODC, however, is widely believed to be a contributing factor in tumorigenesis. Antizyme is a major regulator of ODC, inhibiting ODC activity through the formation of complexes and facilitating degradation of ODC by the 26S proteasome. Moreover, the antizyme inhibitor (AZI) serves as another factor in regulating ODC, by binding to antizyme and releasing ODC from ODC-antizyme complexes. In our previous report, we observed elevated AZI expression in tumor specimens. Therefore, to evaluate the role of AZI in regulating ODC activity in tumors, we successfully down-regulated AZI expression using RNA interference technology in A549 lung cancer cells expressing high levels of AZI. Two AZI siRNAs, which were capable to generate a hairpin dsRNA loop targeting AZI, could successively decrease the expression of AZI. Using biological assays, antizyme activity increased in AZI-siRNA-transfected cells, and ODC levels and activity were reduced as well. Moreover, silencing AZI expression decreased intracellular polyamine levels, reduced cell proliferation, and prolonged population doubling time. Our results directly demonstrate that downregulation of AZI regulates ODC activity, intracellular polyamine levels, and cell growth through regulating antizyme activity. This study also suggests that highly expressed AZI may be partly responsible for increased ODC activity and cellular transformation.",
keywords = "Antizyme, Antizyme inhibitor, Ornithine decarboxylase, siRNA",
author = "Choi, {Kyoung Suk} and Suh, {Young Ho} and Kim, {Won Ho} and Lee, {Tae Ho} and Jung, {Myeong Ho}",
year = "2005",
month = "3",
day = "4",
doi = "10.1016/j.bbrc.2004.11.172",
language = "English",
volume = "328",
pages = "206--212",
journal = "Biochemical and biophysical research communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Stable siRNA-mediated silencing of antizyme inhibitor : Regulation of ornithine decarboxylase activity. / Choi, Kyoung Suk; Suh, Young Ho; Kim, Won Ho; Lee, Tae Ho; Jung, Myeong Ho.

In: Biochemical and Biophysical Research Communications, Vol. 328, No. 1, 04.03.2005, p. 206-212.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Stable siRNA-mediated silencing of antizyme inhibitor

T2 - Regulation of ornithine decarboxylase activity

AU - Choi, Kyoung Suk

AU - Suh, Young Ho

AU - Kim, Won Ho

AU - Lee, Tae Ho

AU - Jung, Myeong Ho

PY - 2005/3/4

Y1 - 2005/3/4

N2 - Ornithine decarboxylase (ODC) is the rate-limiting enzyme involved in the biosynthesis of polyamines essential for cell growth and differentiation. Aberrant upregulation of ODC, however, is widely believed to be a contributing factor in tumorigenesis. Antizyme is a major regulator of ODC, inhibiting ODC activity through the formation of complexes and facilitating degradation of ODC by the 26S proteasome. Moreover, the antizyme inhibitor (AZI) serves as another factor in regulating ODC, by binding to antizyme and releasing ODC from ODC-antizyme complexes. In our previous report, we observed elevated AZI expression in tumor specimens. Therefore, to evaluate the role of AZI in regulating ODC activity in tumors, we successfully down-regulated AZI expression using RNA interference technology in A549 lung cancer cells expressing high levels of AZI. Two AZI siRNAs, which were capable to generate a hairpin dsRNA loop targeting AZI, could successively decrease the expression of AZI. Using biological assays, antizyme activity increased in AZI-siRNA-transfected cells, and ODC levels and activity were reduced as well. Moreover, silencing AZI expression decreased intracellular polyamine levels, reduced cell proliferation, and prolonged population doubling time. Our results directly demonstrate that downregulation of AZI regulates ODC activity, intracellular polyamine levels, and cell growth through regulating antizyme activity. This study also suggests that highly expressed AZI may be partly responsible for increased ODC activity and cellular transformation.

AB - Ornithine decarboxylase (ODC) is the rate-limiting enzyme involved in the biosynthesis of polyamines essential for cell growth and differentiation. Aberrant upregulation of ODC, however, is widely believed to be a contributing factor in tumorigenesis. Antizyme is a major regulator of ODC, inhibiting ODC activity through the formation of complexes and facilitating degradation of ODC by the 26S proteasome. Moreover, the antizyme inhibitor (AZI) serves as another factor in regulating ODC, by binding to antizyme and releasing ODC from ODC-antizyme complexes. In our previous report, we observed elevated AZI expression in tumor specimens. Therefore, to evaluate the role of AZI in regulating ODC activity in tumors, we successfully down-regulated AZI expression using RNA interference technology in A549 lung cancer cells expressing high levels of AZI. Two AZI siRNAs, which were capable to generate a hairpin dsRNA loop targeting AZI, could successively decrease the expression of AZI. Using biological assays, antizyme activity increased in AZI-siRNA-transfected cells, and ODC levels and activity were reduced as well. Moreover, silencing AZI expression decreased intracellular polyamine levels, reduced cell proliferation, and prolonged population doubling time. Our results directly demonstrate that downregulation of AZI regulates ODC activity, intracellular polyamine levels, and cell growth through regulating antizyme activity. This study also suggests that highly expressed AZI may be partly responsible for increased ODC activity and cellular transformation.

KW - Antizyme

KW - Antizyme inhibitor

KW - Ornithine decarboxylase

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=12844280568&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2004.11.172

DO - 10.1016/j.bbrc.2004.11.172

M3 - Article

VL - 328

SP - 206

EP - 212

JO - Biochemical and biophysical research communications

JF - Biochemical and biophysical research communications

SN - 0006-291X

IS - 1

ER -